ANDA 208055, held by Torrent. Lurasidone Hydrochloride.
As of Nov 16, 2026, ANDA 208055 (Lurasidone Hydrochloride), held by Torrent, was first approved by FDA on Jan 13, 2025, with 2 approved supplements and 0 published complete response letters.
| Jan 13, 2025 | Original application | Approved | None posted |
| Jan 3, 2019 | Original application | Approved |
| Lurasidone Hydrochloride20MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| Lurasidone Hydrochloride40MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| Lurasidone Hydrochloride80MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| Lurasidone Hydrochloride120MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| Lurasidone Hydrochloride60MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| Apr 13, 2026 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 13, 2026 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jan 13, 2025 | Original application | Approved | None posted |
| Jan 3, 2019 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters